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Interferon Regulatory Factor 5 (IRF5) plays a major
role in setting up an inflammatory macrophage
phenotype, but the molecular basis of its transcrip-
tional activity is not fully understood. In this study,
we conduct a comprehensive genome-wide analysis
of IRF5 recruitment in macrophages stimulated with
bacterial lipopolysaccharide and discover that IRF5
binds to regulatory elements of highly transcribed
genes. Analysis of protein:DNA microarrays demon-
strates that IRF5 recognizes the canonical IRF-bind-
ing (interferon-stimulated response element [ISRE])
motif in vitro. However, IRF5 binding in vivo appears
to rely on its interactions with other proteins. IRF5
binds to a noncanonical composite PU.1:ISRE motif,
and its recruitment is aided by RelA. Global gene
expression analysis in macrophages deficient in
IRF5 and RelA highlights the direct role of the Re-
lA:IRF5 cistrome in regulation of a subset of key in-
flammatory genes.Wemap the RelA:IRF5 interaction
domain and suggest that interfering with it would
offer selective targeting ofmacrophage inflammatory
activities.
INTRODUCTION
A finely tuned inflammatory response to microbial and endoge-
nous insults is essential for host survival. During inflammation,
gene programs are activated by orchestrated changes in tran-
scription and are determined by transcription factors (TFs) bind-
ing to accessible DNA regulatory elements found in promoters
and enhancers. Ubiquitously expressed TFs such as nuclear
factor-kB (NF-kB), interferon regulatory factors (IRFs), and acti-
vator protein 1 (AP.1) each play a central role in eliciting an in-
flammatory response to extracellular Toll-like receptor 4 (TLR4)
stimulation by lipopolysaccharide (LPS). These ubiquitous
stimulus-inducible TFs appear to work in conjunction with line-
age-restricted constitutive TFs, such as PU.1, to define line-1308 Cell Reports 8, 1308–1317, September 11, 2014 ª2014 The Auage-specific enhancers (Ghisletti et al., 2010; Heinz et al.,
2010). However, the regulatory logic underlying the activation
of specialized gene expression programs is to a large extent un-
known. TFs that respond to tissue-specific microenvironmental
cues and fine-tune cellular identities (Ostuni and Natoli, 2011)
add to the complexity of this regulatory logic.
In this context, we demonstrated that IRF5 is critical in estab-
lishing inflammatory phenotypes in vitro and is involved in the
positive regulation of type 1 T helper (Th1)/Th17-associated
mediators, such as interleukin-1 (IL-1), IL-12, IL-23, and tumor
necrosis factor a (TNF-a) (Krausgruber et al., 2010, 2011). More-
over, IRF5 is capable of repressing anti-inflammatory genes
associated with the macrophage colony-stimulating factor
(M-CSF)-derived phenotype, such as IL-10 (Krausgruber et al.,
2011). A functional consequence of this dual role is demon-
strated by studies showing that IRF5 is essential in the develop-
ment of Th1 responses to Leishmania donovani infection (Paun
et al., 2011) and in the susceptibility to lethal endotoxic shock
(Takaoka et al., 2005). These divergent functions of IRF5 suggest
that IRF5 cooperates with different cofactors at inflammatory
versus homeostatic gene regulatory elements. In fact, we have
reported that IRF5 forms a protein complex with NF-kB RelA to
drive a sustained induction of the human TNF gene (Krausgruber
et al., 2010).
In this study, we used GM-CSF (granulocyte/macrophage-
colony-stimulating factor)-derived macrophages (GM-bone
marrow-derived macrophages [BMDMs]) to investigate whether
the recruitment of IRF5 via its interactions with RelA is a common
mechanism of proinflammatory gene regulation by IRF5. By
intersecting the chromatin immunoprecipitation-sequencing
(ChIP-seq) analysis of the individual TFs in LPS-stimulated
GM-BMDMs with gene expression data and histone methylation
status data sets, we show that the IRF5 and RelA cistromes
target inflammatory genes. The two cistromes overlap only at a
limited number of genomic regions located in the PU.1-marked
regulatory elements of inflammatory genes, 70% of which are
induced upon LPS stimulation, as shown by the recruitment of
RNA polymerase II (PolII). Using in vivo and in vitro motif discov-
ery analyses, we demonstrate that the IRF5:RelA cistrome is
best explained by the presence of consensus NF-kB and nonca-
nonical composite PU.1:interferon-stimulated response elementthors
(ISRE)-binding sites. We demonstrate that IRF5 genome recruit-
ment to inflammatory genes is aided by RelA. These results
reveal a genomic strategy for controlling an inflammatory gene
program in GM-BMDMs via establishment of a unique IRF5:RelA
cistrome to target inflammatory genes.
RESULTS
Genome-wide Alignment of IRF5 and RelA Binding in
GM-CSF BMDMs
To investigate the model of IRF5-RelA transcriptional coopera-
tion, ChIP-seq was used to determine the genome-wide binding
of IRF5, RelA, and PolII in GM-BMDMs stimulatedwith LPS or left
unstimulated. Upon LPS stimulations, these macrophages are
predominantly homogeneous IRF5-positive cells that display a
distinct phenotype of cytokine and cell surface molecule expres-
sion compared to M-CSF (CSF-1) (M)-BMDMs (Figure S1A)
(Fleetwood et al., 2007; Weiss et al., 2013). ChIP-seq libraries
were prepared for untreated cells or cells treated for 0.5 or 2 hr
with LPS. Nonimmunoprecipitated input DNA isolated under
the same conditions was also subjected to sequencing. Enriched
bound genomic regions (peaks) were identified using the ZINBA
(zero-inflated negative binomial algorithm; Rashid et al., 2011)
at a false discovery rate (FDR) of 1% (Table S1A). We identified
1,252, 6,052, and 8,805 RelA peaks (RelA cistrome) and 3,591,
4,157, and 4,213 IRF5 peaks (IRF5 cistrome) at 0, 0.5, and 2 hr,
respectively, post-LPS stimulation (Table S1B). The scatterplot
analysis of the data sets demonstrated a strong influence of
LPS stimulation on both RelA and IRF5 recruitment (Figures
S1B and S1C). We also found an 80% overlap of RelA peaks
identified in this study to peaks inGM-CSF-derived dendritic cells
(GM-bone marrow dendritic cells [BMDCs]) (Garber et al., 2012).
As a control for the IRF5 data set, we performed IRF5 ChIP quan-
titative PCR (ChIP-qPCR) in IRF5 knockout (KO) and wild-type
(WT) cells stimulated with LPS and demonstrated a specific
enrichment in IRF5 binding at the ChIP-seq-identified peaks in
WT cells (Figure S1C). We also identified 1,679 and 4,879 PolII
peaks 0.5 and 2 hr, respectively, post-LPS stimulation.
Some illustrative binding regions are shown in Figure 1A,
including the lymphotoxin-a (Lta), Ltb, and Tnf gene cluster, che-
mokine (C-Cmotif) ligand 5 (Ccl5), IL-1a (Il-1a), and other immune
related gene loci. In the case of the Tnf gene cluster, IRF5 and
RelA show similar binding patterns as we previously reported in
human monocyte-derived dendritic cells (Krausgruber et al.,
2010). The peaks called by the ZINBA in these representative re-
gions indicate considerable overlap of IRF5 and RelA binding to
this gene locus. In general, IRF5 binding was found to co-occur
frequently with RelA binding (801 peaks at 1% FDR) (Figure 1B).
Using a simulation procedure that controls for genomic back-
ground (Ponjavic et al., 2009), we observe that the overlap
between RelA- and IRF5-binding sites is 3.4-fold greater than ex-
pected (p < 104). Therefore, the overlap of IRF5 and RelA bind-
ing initially observed in the Tnf gene cluster (Krausgruber et al.,
2010) (Figure 1A) reflects a genome-wide phenomenon. Of
interest, a significant enrichment in co-occurrence of RelA peaks
with another member of the IRF family, IRF1, but not with IRF2 or
IRF4,was observed in a high-throughput analysis of TF binding in
GM-BMDCs (Garber et al., 2012).Cell ReUsing the simulation procedure described above, we
observed a 21-fold (p < 104) increase in IRF5 recruitment
following LPS stimulation for 2 hr (Table S1C). IRF5 peaks
were also observed downstream of the 30 UTRs of protein-cod-
ing genes (Table S1C; Figure S1D), with 33% of IRF5-targeted
genes containing an IRF5 peak downstream of the transcription
end site (Figure S1E). Binding of RelA upstream of transcription
start sites (TSSs) amounted to 19% of all peaks at 2 hr post-
LPS stimulation, but no significant enrichment in binding to inter-
genic, intronic, and downstream regions was observed (Table
S1D). Correspondingly, the proportion of RelA peaks that co-oc-
cur with IRF5 peaks (IRF5:RelA cistrome) is markedly increased
in the proximal 1 kb regions upstream of the TSS (5.2-fold
change; p < 0.0001; Figure 1C). In summary, these analyses
highlight that up to 20% of IRF5- and RelA-binding events occur
within a limited part of the genome, namely the relatively short re-
gions just upstream of protein-coding genes.
IRF5 and RelA Cistromes Intersect at PU.1-Marked
Regulatory Elements of LPS-Induced Genes
To understand whether the binding of IRF5 and RelA influences
PolII recruitment, we analyzed the degree of genome-wide over-
lap between IRF5 and RelA with PolII occupancy following 2 hr of
LPS stimulation. PolII peaks overlapped with the IRF5:RelA cis-
trome (>116-fold over genomic background; p < 104) more
prominently than with the rest of either RelA or IRF5 peaks (Fig-
ure 2A). Analysis of the degree of PolII overlap with TSSs demon-
strated increased overlap with TSSs when both IRF5 and RelA
bind the gene upstream region (Figure S2A). Moreover, when
we combined IRF5- and RelA-binding data with microarray
gene expression data at the same time point, we noted that
the peaks of the IRF5:RelA cistrome were centered around the
TSS of strongly upregulated genes, whereas the RelA peaks
that did not overlap with IRF5 displayed more uniform distribu-
tion in both upregulated and downregulated genes around the
TSS (Figure 2B). Further analysis of gene expression across
the stratified ChIP-seq peaks revealed that genes targeted by
both RelA and IRF5 were significantly more upregulated than
either RelA (p < 107) or IRF5 (p < 1012) acting independently
(Figure 2C). Among 340 strongly (>2-fold; FDR, 1%) upregulated
genes, 74 were targeted by both RelA and IRF5 (Table S2C).
RelA binding explains a similar number of upregulated genes,
whereas IRF5 explains fewer. Of interest, the individual presence
of IRF5 at the gene promoter explains a much larger propor-
tion of 202 strongly downregulated (>2-fold; FDR, 1%) genes
(Table S2A).
Next, we examined whether the RelA and IRF5 cistromes
show characteristic chromatin signatures of functional genomic
elements, i.e., enhancers and promoters marked by relatively
high levels ofmonomethylation or trimethylation of lysine 4 of his-
tone 3 (H3K4), respectively. To do this, we intersected the data
sets with H3K4me1/H3K4me3-positive regions from M-BMDMs
(Heinz et al., 2010) and GM-BMDCs (Garber et al., 2012). IRF5
and RelA peaks associated with both H3K4Me1 and H3K4Me3
chromatin marks (p < 104; Table S2B).
It has recently been shown that binding of a pioneer TF PU.1 is
essential for defining macrophage-specific enhancers because
it promotes the deposition of H3K4me1 (Ghisletti et al., 2010;ports 8, 1308–1317, September 11, 2014 ª2014 The Authors 1309
Figure 1. Distribution of IRF5- and RelA-Bound Regions in the Genome following LPS Stimulation
(A) Representative USCS Genome Browser tracks in the Tnf,Ccl5, and Il-1a loci for IRF5 (blue), RelA (red), PolII (green), and Input (black) of unstimulated (0 hr) or
LPS-stimulated (2 hr) GM-BMDMs. Overlapping IRF5 and RelA regions are highlighted in gray.
(B) IRF5 reads colocalize with RelA peaks. The ChIP-seq data sets for RelA and IRF5 (±2 kb) were each aligned with respect to the center of the RelA peaks and
sorted by the height of the RelA-marked regions. Each line represents a RelA peak. A total of 1,000 representative peaks are shown.
(C) Fold enrichment of RelA ChIP-seq peaks with (white bars) or without (black bars) IRF5 was aligned to the nearest gene structures in which 5 kb upstream/
downstream regions were split into 1 kbwindows. A 5.2-fold enrichment of overlapping RelA and IRF5 peaks at the proximal 1 kb region to 3.7-fold for RelA peaks
that do not co-occur with IRF5 (p = 104, as defined by simulation procedure; see Experimental Procedures).
See also Figure S1 and Table S1.Heinz et al., 2010). Here, we examined the aggregated densities
of PU.1 reads reported in Garber et al. (2012) over IRF5:RelA
peaks and found that they align perfectly with the peaks of
H3K4me1 and H3K4me3 deposition at enhancers and pro-
moters, respectively, with the notable bimodal distribution of
histone marks indicative of nucleosome depletion (Figure S2A).
Moreover, binding of IRF5:RelA peaks occurred at both PU.1-
marked promoters and enhancers (p < 104; Table S2C). Thus,
the genes that expression is strongly induced in macrophages
by LPS are under the control of the IRF5:RelA cistrome, which
is centered around the TSS.
The IRF5:RelA Cistrome Targets Regulatory Elements of
Key Inflammatory Genes
To identify genes that are directly and functionally affected by
either the IRF5:RelA cistrome or IRF5 and RelA acting individu-
ally, we first categorized promoters (up to 10 kb upstream and1310 Cell Reports 8, 1308–1317, September 11, 2014 ª2014 The Au0.5 kb of the TSS) of the genes into three categories. These
consist of genes that encompass ChIP-seq peaks present in
(1) both IRF5 and RelA, (2) only RelA, or (3) only IRF5 (Figure 3A).
We next performed global expression profiling to identify LPS-
affected genes that are differentially expressed in either GM-
BMDMs from IRF5 conventional KO or conditional RelA KO
(RelA Fl/Fl Mx1Cre) (Luedde et al., 2008) compared to WT
mice (Figure 3B). The expression profiles of GM-BMDMs at 0,
1, 2, 4, and 8 hr after LPS stimulation were analyzed for differ-
ential gene expression. IRF5 or RelA deficiency resulted in
inhibition of a very selective subset of category 1 genes that en-
compassed key inflammatory mediators (defined as Panther
Pathway ‘‘Inflammation mediated by chemokine and cytokine
signaling pathway’’; Hyper FDR, q <1010), such as Il-6, Il-12a,
Il-1a, Fpr2, Aoah, Adam17, Cxcl2, and Saa3 (Figure 3C). More-
over, expression of some other important inflammatory genes
was affected by either only IRF5 deletion (Mmp25 and Socs3)thors
Figure 2. IRF5 and RelA Colocalize at TSSs
of Positively Regulated Genes
(A) IRF5 and RelA complex colocalizes with PolII
peaks. The ChIP-seq reads for RelA without IRF5,
RelA with IRF5, and IRF5 without RelA were each
alignedwith respect to the center of the PolII peaks
and sorted by the height of the PolII-marked re-
gions. A total of 500 representative peaks are
shown.
(B) Bubble plot representation of RelA-binding
sites around differentially regulated genes. The
plots indicate the position of ChIP-seq peaks with
respect to the closest TSS (x axis) and the
observed fold change (y axis) in microarray
expression experiments. The size of a bubble de-
notes the strength of the ChIP-seq peak. Red
bubbles indicate RelA with IRF5; blue bubbles
indicate RelA without IRF5.
(C) Box plot of gene expression fold change
differences upon LPS stimulation with three cate-
gories of binding events in their vicinity as indi-
cated. The fold change differences are significant
(Mann-Whitney U test).
See also Figure S2 and Table S2.or only RelA (e.g., Tnfaip3, Itgav, Malt1, Icam1, and Sod2) (Fig-
ure 3C). In category 2 genes, we observe that RelA, but not
IRF5, KO has a direct effect on expression at, for example,
Lcn2, Fas, H2-M2, Clec4a1, Casp7, and Nlrp3 gene loci (Fig-
ure S3; Table S3). In category 3 genes, we observe that the
lack of IRF5, but not RelA, has affected expression of, for
example, Nos2, a key marker of M1 activity (Figure S3; Table
S3). The observation that the expression of some genes in cate-
gory 2 is affected by IRF5 KO and some genes in category 3 by
RelA KO indicates an indirect effect via a secondary regulator in a
feedforward loop (Mangan and Alon, 2003). In total, we find that
263 and 499 transcriptionally active genes are affected by the
lack of IRF5 or RelA, respectively. Consistent with the published
data demonstrating that most RelA target sites were not associ-
ated with transcriptional changes (Lim et al., 2007), at many loci,
IRF5 or RelA binding did not directly correlate with change in
gene expression, even in the absence of a TF. It is possible
that previously noted ‘‘billboard’’ organization of immune genes’
promoters (Garber et al., 2012) allows for a degree of redundant
recruitment of TFs. Hence, the combined global profiling of IRF5-Cell Reports 8, 1308–1317, Sepand RelA-bound sites and gene expres-
sion in cells deficient in either TF has high-
lighted the direct role of the IRF5:RelA
cistrome in transcriptional regulation of
selective key inflammatory genes.
The Presence of Canonical kB
and Composite PU.1:ISRE Sites
Is Characteristic of the IRF5:RelA
Cistrome
To better understand the regulatory code
at inflammatory loci, we first performed
ab initio DNA motif analysis around the
top 500 RelA and IRF5 peaks. Motif anal-ysis revealed the known kB motif (Natoli et al., 2011; Siggers
et al., 2012) in RelA peaks (Figure 4A). The same analysis of
IRF5 peaks found no motifs similar to known canonical ISRE,
A/GNGAAANNGAAACT (Badis et al., 2009; Tamura et al.,
2008) (Figure 4A). However, the PU.1-binding motif was the
top-scoring motif enriched in the IRF5 peaks (Figure 4A). The
other top-binding motif in this data set included TFs recognizing
CpG-rich sequences that are associated with gene promoters,
such as Sp1 (Figure 4A). Interestingly, the binding regions co-
occupied by IRF5 and RelA were enriched in kB site and binding
motif that resembled a composite PU.1:ISRE, with the PU.1 site
(Figure 4A, boxed) adjacent to the ISRE half-site (Figure 4A). This
site was previously reported for immune cell development-
related IRF4 and IRF8 (Brass et al., 1996; Escalante et al.,
2002; Tamura et al., 2005). Additionally, whereas RelA binds to
the kB site in the absence of IRF5, the latter is likely to bind to
the CpG-rich sequence SP1 in the absence of RelA (Figure 4A).
Thus, themode of IRF5 in vivo binding groups it with immune cell
development-related IRFs and strongly suggests that such IRF
proteins exert their function as cofactors and not individually.tember 11, 2014 ª2014 The Authors 1311
Figure 3. Association of IRF5:RelA-Bound
Genes with Immune Genes
(A) Schematic of promoters bound by IRF5 and
RelA. Each promoter (10 kb upstream and 0.5 kb of
the TSS) containing IRF5 and/or RelA ChIP-seq
peaks was classified into (1) bound by both IRF5
and RelA, (2) bound by RelA but not IRF5, or (3)
bound by IRF5 but not RelA.
(B) Genome-wide profiling of LPS-affected genes
in GM-BMDMs from either conventional IRF5 KO
or conditional RelA KO (RelA Fl/Fl Mx1Cre; in
which Mx1-Cre expression was induced by
PolyI:C) compared to WT. Number of genes in
each category significantly affected by KO of IRF5
or RelA (>2-fold; FDR, 1%) is shown (Down,
regulator induces gene; Up, regulator represses
gene). IRF5 KO resulted in 164 downregulated
genes and 99 upregulated genes compared toWT.
RelA KO resulted in 263 downregulated genes and
236 upregulated genes compared to WT.
(C) Gene expression heatmaps of category 1
genes. GM-BMDMs from conventional IRF5 KO
(left panel) or conditional RelA KO each compared
to WT controls following stimulation by LPS for 0,
1, 2, 4, or 8 hr are shown; underlining indicates
genes that are affected in both IRF5 and RelA KO.
(Data are pooled from three experiments; blue to
red represents increase level of gene expression.)
See also Figure S3 and Table S3.Because ChIP only identifies genomic regions that interact
with TFs but not necessarily individual binding sites (Gorda^n
et al., 2009; Jolma et al., 2010; Wong et al., 2011), we used pro-
tein-binding microarrays (PBMs) for purified recombinant IRF3
and IRF5 protein tomap the site of TF-DNA interactions with pre-
cision. For comparison, PBM data for RelAp50 were used from
Wong et al. (2011). We analyzed 3,072 12-mer sequences de-
signed around the ISRE consensus (see Experimental Proce-
dures) carrying 4 different flanks. The sequences were ranked
and used to produce binding motifs. The logo emerging from
the top 50 binders was very similar to the one obtained by Badis
et al. (2009), whereas the top 500 sequences produced a motif
that was less stringent in positions 6, 9, and 11 (Figure S4, bot-
tom panel).
All the IRF5- and RelAp50-binding sequences with their
respective Z scores were used to perform receiver operating
characteristic (ROC) curve analyses using the IRF5 and RelA cis-
tromes from this study to quantify whether the IRF5- or RelA-
bound regions (true positives) scored higher than the unbound
regions (true negatives), similar to Siggers et al. (2012). We
observed equally large areas under the ROC curve (AUC) when
RelAp50 kmers were used to explain the IRF5:RelA cistrome
peaks (AUC, 0.68) or the rest of RelA peaks (AUC, 0.65)
compared to true negatives (Figure 4B). Thus, we concluded
that RelAp50 binds to sequences in vivo that resemble its
DNA-binding preferences in vitro. In contrast, AUC enrichment
scores for IRF5 kmers demonstrated low nondiscriminating
enrichment scores for the peaks of the IRF5:RelA cistrome
(AUC, 0.53) and the rest of IRF5 peaks (AUC, 0.50) (Figure 4C).1312 Cell Reports 8, 1308–1317, September 11, 2014 ª2014 The AuTogether with the ab initio analysis above, we therefore inter-
pret this result as evidence that at the inflammatory gene loci,
IRF5 is likely to be recruited to a composite PU.1:ISRE site rather
than to a canonical ISRE site, whereas RelA binds directly to the
respective kB site. The dynamics of PU.1 and IRF5 binding at the
PU.1:ISRE composite sites are unclear and warrant further
investigation.
RelA Aids in IRF5 Recruitment to Promoters of
Inflammatory Genes
We previously reported that IRF5 can functionally interact with
RelA at the human TNF locus (Krausgruber et al., 2010). Here,
we addressed the question whether recruitment of IRF5 to in-
flammatory gene loci is commonly mediated by RelA. We exam-
ined IRF5 recruitment to the selected genes, expression of which
was shown to be directly dependent on IRF5 (Figures 3B and
S5A) in cells with depleted levels of RelA. GM-BMDMs were
generated from the bone marrow of RelAFl/Fl mice (Luedde
et al., 2008) and infected with Cre-expressing adenovirus. Effi-
ciency of RelA deletion was about 50% as judged by analysis
of residual RelA protein by western blot (Figure S5B). Following
stimulation with LPS for 2 hr, recruitment of IRF5, as well as
RelA and PolII, to the Il-1a, Il-6, and Tnf genomic loci was
analyzed by ChIP-qPCR. We observed a significant reduction
in IRF5 binding to the regions of overlapping IRF5:RelA peaks
(Figure 5A). Thus, together with the previously observed depen-
dence of IRF5 binding to the 30 region of the human TNF gene
(Krausgruber et al., 2010), our results suggest that recruitment
of IRF5 to DNA at inflammatory gene loci is assisted by RelA.thors
Figure 4. Enrichment of PBM-Determined kB Sites, but Not ISREs, in ChIP-Seq Peaks
(A) A parallel version of Multiple EM forMotif Elicitation-ChIP (Machanick and Bailey, 2011) was used to perform a de novo sequence search in the five subtypes of
ChIP binding using 500 top-binding sequences in each category. The PU.1motif (GGAA) and Sp1motif were derived for the entire IRF5 data set. The kB and PU.1
motifs were derived for the entire RelA data set. The kB and composite PU.1 (boxed):ISRE motifs were derived for overlapping RelA and IRF5 peaks. The Sp1
motif was derived for the IRF5 data set in the absence of RelA, and the kB site was derived for the RelA data set in the absence of IRF5. (All motifs shown have an e
value of <105.)
(B) ROC curve analysis quantifying enrichment within RelA-bound regions (blue indicates with IRF5; red indicates without IRF5) of RelA-p50 PBM-determined
sites.
(C) ROC curve analysis quantifying enrichment within IRF5-bound regions (blue indicates with RELA; red indicates without RelA) of IRF5 PBM-determined ISREs.
AUC values quantify enrichment. (Wilcoxon-Mann-Whitney U test, **p < 1029; *p < 107.)
See also Figure S4.To map the interacting domains, we generated in-frame One-
STrEP and HA-tagged truncation mutants of the key domains of
IRF5 (Figure 5B, top panel) and FLAG-tagged truncationmutants
of the key domains of RelA (Figure 5C, top panel). IRF5 trunca-
tion mutants or p50 (as positive control) was coexpressed to
equal levels in HEK293-TLR4-CD14/Md2 cells along with RelA-
Flag or BAP-Flag as negative control. The resulting lysates
were subjected to One-STrEP immunoprecipitation, and the
precipitated proteins were analyzed by immunoblotting with
anti-HA antibody. The truncation mutants IRF5-DN219 and
IRF5-N395 were comparable to the WT protein in binding
RelA-Flag. In contrast, removal of the IRF association domain
(IAD) in truncation mutants IRF5-N130 and IRF5-N220 resulted
in impaired binding to RelA-Flag (Figure 5B, bottom panel).
Flag-tagged RelA truncation mutants or BAP-Flag as negative
control was coexpressed to similar levels along with One-
STrEP-IRF5, subjected to One-STrEP immunoprecipitation,
and the precipitated proteins were analyzed by immunoblotting
with anti-FLAG antibody. The removal of the dimerization
domain (DD) in truncationmutant RelA-N186 resulted in impairedCell Rebinding to One-STrEP-IRF5 (Figure 5C, bottom panel). Thus,
IRF5 IAD and RelA DDs are critical for IRF5-RelA interactions.
DISCUSSION
An emerging view on the transcriptional networks that dictate the
response ofmacrophageswhile encounteringmicrobial stimuli is
that they consist of pioneer lineage-specific (e.g., CEBPb, PU.1),
basal (e.g., JunB, ATF3), and stimulus-inducible (NF-kB, IRFs,
AP.1) TFs (Garber et al., 2012). Here, we investigated how TFs
that define functional macrophage specialization (Garber et al.,
2012; Ghisletti et al., 2010; Heinz et al., 2010), such as IRF5,
contribute to the determination or regulation of specific subsets
of the regulatory elements. We demonstrate that IRF5 is re-
cruited to such elements of LPS-induced inflammatory genes
and is essential for their efficient transcription. We find that NF-
kB RelA assists IRF5 in binding to DNA, and the two factors
set up a unique ‘‘inflammatory’’ IRF5:RelA cistrome. We also
map the interface of IRF5:RelA interactions, paving the way to
possible new therapeutics, that would specifically reduceports 8, 1308–1317, September 11, 2014 ª2014 The Authors 1313
Figure 5. IRF5:RelA Interaction Occurs via
the IRF IAD and RelA DD
(A) GM-BMDMs from RelAFl/Fl mice were infected
with either Cre or Empty adenovirus and stimu-
lated with LPS (100 ng/ml) for 2 hr or left un-
stimulated and used in ChIP analysis for IRF5,
RELA, or PolII recruitment on Il-6, Il-1a, and TNF
loci. Data indicate mean percent input relative to
genomic DNA ± SD of a representative experi-
ment.
(B) Schematic of IRF5 truncationmutants prepared
by PCR using IRF5 cDNA as a template. Each
mutant was cloned into pBent vector with One-
STrEP and HA tags at the N terminus. HEK293-
TLR4-Md2/CD14 cells were cotransfected with
either RelA-Flag (lanes 1–7) or Bap-Flag (lanes 8–
13) and each of the IRF5 truncation mutants (lanes
2–6 and 8–12) or p50 (lane 7 and 13) as a positive
control. Following immunoprecipitation (IP) on M2
anti-Flag beads, the Flag peptide eluates were
immunoblotted for IRF5 truncation mutants (anti-
HA antibody; top panel) and bait (anti-Flag anti-
body; middle panel). Immunoblots of input lysate
show equal expression of bait IRF5 truncation
mutants (anti-HA; bottom panel). RelA interacts
with IRF5 WT (lane 2) and truncation mutants
possessing the IAD (lanes 3 and 5), but notmutants
lacking the IAD (lanes 4 and 6). WB, western blot.
(C) Schematic of RelA truncation mutants pre-
pared by PCR using IRF5 cDNA as a template.
Each mutant was cloned into pBent vector with
FLAG tag at the N terminus. HEK293-TLR4-Md2/
CD14 cells were cotransfected with full-length
RelA-FLAG (lane 1), truncated RelA-FLAGmutants
(lanes 2–3), BAP-FLAG (lane 4), or pBent (lane 5)
and One-STrEP-IRF5. Immunoblots of input lysate
show equal expression of prey RelA truncation
mutants (anti-FLAG; bottom panel). Following af-
finity purification on Strep-Tactin beads, the biotin
eluates were immunoblotted for RelA truncation
mutants (anti-FLAG; top panel). Immunoblots of
the eluates show equal recovery of the bait One-
STrEP-IRF5 (middle panel). IRF5 interacts with
RelA WT and truncation mutants containing DD
(lanes 1, 3, and 4), but not mutants lacking the DD
(lane 2).
See also Figure S5.inflammatory activities, without having deleterious effects on the
whole innate immunity that is an essential first line of defense
against microbes.
Binding of a pioneer TF, PU.1, inmacrophages is thought to be
sufficient to promote the deposition of H3K4me1 and to create
small open regions of accessible DNA that can be bound by
stress-inducible dynamic TFs, such as NF-kB and IRFs (i.e., en-1314 Cell Reports 8, 1308–1317, September 11, 2014 ª2014 The Authorshancers) (Natoli et al., 2011). Less clear is
whether PU.1 also promotes the deposi-
tion of H3K4me3 and chromatin opening
at gene promoters. We find that PU.1
binding corresponds to the peaks of
both H3K4me1 and H3K4me3 deposition
and demonstrates bimodal distributionof histone marks indicative of nucleosome depletion. Binding
of IRF5:RelA is significantly enriched on PU.1-marked regulatory
elements. This is in line with previous studies that indicated that a
subset of macrophage PU.1-marked enhancers was enriched
for both NF-kB and IRFs (Ghisletti et al., 2010). Moreover, we
find that the IRF5:RelA cistrome encompasses a noncanonical
composite PU.1:ISRE. We observed that IRF5 can also
physically interact with PU.1 (data not shown), whereas others
recently demonstrated that a preferred mode of IRF5 binding
may actually be to a half ISRE site (Jolma et al., 2013). More
work is needed to tease out the dynamics of RelA and PU.1
involvement in the binding of IRF5, but it is highly likely that
PU.1 binds first because it functions as a pioneering factor in
macrophages (Garber et al., 2012; Ghisletti et al., 2010; Heinz
et al., 2010), followed by the binding of RelA at inflammatory
gene loci and subsequently docking of IRF5. Thus, in inflamma-
tory macrophages, IRF5 imposes yet another previously unob-
served level of control on the transcriptional network.
Can this be a mode of binding at other gene loci identified in
this study as IRF5 but not RelA targets? The interactome of
IRF5 is rapidly expanding (Eames et al., 2012; Feng et al.,
2010); thus, it is possible that other yet to be identified TFs
may aid to recruit IRF5 to other gene promoters in the absence
of RelA binding. We found a strong enrichment in SP1-binding
motif under IRF5 ChIP-seq peaks, suggesting that this factor
might be involved in high-order transcriptional complexes con-
taining IRF5. Supporting this model is a recent analysis of IRF5
binding in human peripheral blood mononuclear cells stimulated
with immune complexes that also identified Sp1 as one of the
major motifs in IRF5 target regions (Wang et al., 2013).
It is possible that IRF5 acts similarly to another member of
the IRF family, IRF3, which was shown to promote transcription
by removing a nucleosome barrier (Ramirez-Carrozzi et al.,
2009). IRF5 interacts with a number of chromatin modifiers
including acetyltransferases (CBP/300), which were specifically
recruited to the interferon a promoter in response to viral induc-
tion (Feng et al., 2010). However, it is unlikely that IRF5 plays a
causative role in the initial chromatin remodeling because bind-
ing of NF-kB, which assists IRF5 in recruitment to inflammatory
gene loci, requires nucleosome-free DNA (Lone et al., 2013;
Natoli, 2012). Can IRF5 play a role in chromatin remodeling at
later stages of gene expression? We have recently demon-
strated that IRF5 interacts with KAP1 to indirectly recruit
SETDB1 methyltransferase, ultimately leading to deposition of
H3K9me3—a mark of transcriptional repression (Eames et al.,
2012).
IRF5 is a genetic risk factor for many autoimmune diseases,
including systemic lupus erythematosus, rheumatoid arthritis,
multiple sclerosis, and inflammatory bowel disease (Dideberg
et al., 2007; Dieguez-Gonzalez et al., 2008; Graham et al.,
2006; Kristjansdottir et al., 2008). Anti-inflammatory drugs that
target molecules that are pivotal to the inflammatory process,
like TNF and COX2, have proved successful, but the ultimate
aim would be to target transcription of a specific subset of proin-
flammatory genes (Smale, 2010). Inhibiting IRF5 activity may
pave the way for the development of more selective drugs tar-
geting the basic mechanisms underlying the inflammatory
response.
EXPERIMENTAL PROCEDURES
Mice
The generation of Irf5/mice has been described by Takaoka et al. (2005). All
procedures were approved by the Ethical Review Process Committee and the
UK Home Office, in accordance with the Animals (Scientific Procedures) Act
1986.Cell ReCell Culture
For the generation of M1 macrophages differentiated with GM-CSF, bone
marrow of WT C57Bl6 mice was cultured in RPMI-1640 medium (PAA Labora-
tories) supplemented with recombinant mouse GM-CSF (20 ng/ml; Prepro-
Tech). After 8 days, cells were washed with PBS and replated, then stimulated
with LPS (100 ng/ml; Alexis Biochemicals).
ChIP-Seq
Nuclear lysates of formaldehyde-fixed GM-CSF macrophages were isolated
as described previously by De Santa et al. (2007). Each lysate was immunopre-
cipitated with 10 mg of the following antibodies: IRF5 (Abcam; ab21689), RelA
(Santa Cruz Biotechnology; sc-372), and PolII (Santa Cruz; sc-899). ChIP was
performed for each antibody as described previously by Ghisletti et al. (2010).
Please note that independent IRF5 ChIP-seq data sets were recently gener-
ated by us in WT and IRF5/ GM-BMDMs with 50 bp paired-end sequencing
following stimulation with LPS for 0 and 2 hr. Preliminary analysis of these data
sets by MACS2 algorithm with filtering out of peaks detected in the IRF5/
from the WT corroborated the findings reported in this manuscript. Further
details of next-generation sequencing and analysis are provided in the Supple-
mental Experimental Procedures.
Microarray Analysis
Microarray (accession number E-MTAB-2032) data were analyzed in R/bio-
conductor using the beadarray (version 2.4.2; Dunning et al., 2007). Differen-
tially expressed genes were called with SAM method (Tusher et al., 2001)
applying an FDR threshold of 10%.
ACCESSION NUMBERS
The ArrayExpress accession numbers for themicroarray data, single-endChIP
seq data, and paired-end ChIP-seq data reported in this paper are, respec-
tively, E-MTAB-2032, E-MTAB-2031, and E-MTAB-2661.
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